BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22133375)

  • 1. Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte.
    Dickey DM; Dries DL; Margulies KB; Potter LR
    J Mol Cell Cardiol; 2012 Mar; 52(3):727-32. PubMed ID: 22133375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart.
    Dickey DM; Flora DR; Bryan PM; Xu X; Chen Y; Potter LR
    Endocrinology; 2007 Jul; 148(7):3518-22. PubMed ID: 17412809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
    Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M
    Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications.
    Ichiki T; Schirger JA; Huntley BK; Brozovich FV; Maleszewski JJ; Sandberg SM; Sangaralingham SJ; Park SJ; Burnett JC
    J Mol Cell Cardiol; 2014 Oct; 75():199-205. PubMed ID: 25117468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts.
    Meier S; Andressen KW; Aronsen JM; Sjaastad I; Hougen K; Skomedal T; Osnes JB; Qvigstad E; Levy FO; Moltzau LR
    Eur J Pharmacol; 2017 Oct; 812():174-183. PubMed ID: 28697992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-type natriuretic peptide and the guanylyl cyclase receptors in the rat ovary are modulated by the estrous cycle.
    Jankowski M; Reis AM; Mukaddam-Daher S; Dam TV; Farookhi R; Gutkowska J
    Biol Reprod; 1997 Jan; 56(1):59-66. PubMed ID: 9002633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal regulation of natriuretic peptide system during induced ovarian follicular development in the rat.
    Gutkowska J; Jankowski M; Sairam MR; Fujio N; Reis AM; Mukaddam-Daher S; Tremblay J
    Biol Reprod; 1999 Jul; 61(1):162-70. PubMed ID: 10377045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The indolocarbazole, Gö6976, inhibits guanylyl cyclase-A and -B.
    Robinson JW; Lou X; Potter LR
    Br J Pharmacol; 2011 Sep; 164(2b):499-506. PubMed ID: 21366551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-type natriuretic peptide and brain natriuretic peptide inhibit adenylyl cyclase activity: interaction with ANF-R2/ANP-C receptors.
    Savoie P; de Champlain J; Anand-Srivastava MB
    FEBS Lett; 1995 Aug; 370(1-2):6-10. PubMed ID: 7649305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of natriuretic peptide receptor subtypes in the AtT-20 pituitary tumour cell line.
    Gilkes AF; Ogden PH; Guild SB; Cramb G
    Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):481-7. PubMed ID: 8172609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
    Crook RB; Chang AT
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation.
    Dickey DM; Potter LR
    J Mol Cell Cardiol; 2011 Jul; 51(1):67-71. PubMed ID: 21459096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.
    Suga S; Nakao K; Hosoda K; Mukoyama M; Ogawa Y; Shirakami G; Arai H; Saito Y; Kambayashi Y; Inouye K
    Endocrinology; 1992 Jan; 130(1):229-39. PubMed ID: 1309330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle.
    Afzal F; Qvigstad E; Aronsen JM; Moltzau LR; Sjaastad I; Skomedal T; Osnes JB; Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Dec; 384(6):543-53. PubMed ID: 21901315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal overgrowth-causing mutations mimic an allosterically activated conformation of guanylyl cyclase-B that is inhibited by 2,4,6,-trinitrophenyl ATP.
    Dickey DM; Otto NM; Potter LR
    J Biol Chem; 2017 Jun; 292(24):10220-10229. PubMed ID: 28450398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.
    Ichiki T; Huntley BK; Sangaralingham SJ; Burnett JC
    JACC Heart Fail; 2015 Sep; 3(9):715-23. PubMed ID: 26362447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
    Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
    J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
    Hirose M; Furukawa Y; Kurogouchi F; Nakajima K; Miyashita Y; Chiba S
    J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
    Klaiber M; Kruse M; Völker K; Schröter J; Feil R; Freichel M; Gerling A; Feil S; Dietrich A; Londoño JE; Baba HA; Abramowitz J; Birnbaumer L; Penninger JM; Pongs O; Kuhn M
    Basic Res Cardiol; 2010 Sep; 105(5):583-95. PubMed ID: 20352235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.